IBRUTINIB COMPARED TO IMMUNO-CHEMOTHERAPY FOR CENTRAL NERVOUS SYSTEM RELAPSE OF MANTLE CELL LYMPHOMA: A REPORT FROM FONDAZIONE ITALIANA LINFOMI (FIL) AND EUROPEAN MANTLE CELL LYMPHOMA NETWORK (EMCLN)

EHA Library, Chiara Rusconi, 295049

ROLE OF RADIOTHERAPY AND DOSE-DENSIFICATION OF R-CHOP IN PRIMARY MEDIASTINAL B-CELL LYMPHOMA: A SUBGROUP ANALYSIS OF THE UNFOLDER TRIAL OF THE GERMAN LYMPHOMA ALLIANCE (GLA)

EHA Library, Gerhard Held, 295050

QUANTITATIVE PARAMETERS FROM INTERIM PET/CT AFTER TWO R-CHOP14 CYCLES IDENTIFY POOR-RISK DLBCL PATIENTS: RESULTS FROM THE PROSPECTIVE SAKK38/07 CLINICAL STUDY

EHA Library, Emanuele Zucca, 295051

INOTUZUMAB OZOGAMICIN PLUS R-CVP IS A FEASIBLE AND EFFECTIVE REGIMEN FOR FRONTLINE TREATMENT OF DLBCL IN PATIENTS WHO ARE UNFIT FOR R-CHOP: RESULTS OF A RANDOMISED PHASE 2 UK NCRI TRIAL

EHA Library, Elizabeth Phillips, 295052

INITIAL RESULTS OF A PHASE 2 STUDY OF LONCASTUXIMAB TESIRINE, A NOVEL PYRROLOBENZODIAZEPINE-BASED ANTIBODY-DRUG CONJUGATE, IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Carmelo Carlo-Stella, 295053

EFFICACY AND SAFETY OF ATEZOLIZUMAB + OBINUTUZUMAB + VENETOCLAX IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMAS: PRIMARY ANALYSIS OF A PHASE 2 TRIAL FROM LYSA

EHA Library, Charles Herbaux, 295054

OUTCOME OF LIMITED STAGE PERIPHERAL T-CELL LYMPHOMA AFTER CHOP(-LIKE) THERAPY: A POPULATION BASED STUDY OF 251 PATIENTS FROM THE NORDIC LYMPHOMA EPIDEMIOLOGY GROUP

EHA Library, Ahmed Ludvigsen Al-Mashhadi, 295055

HIGH DOSE METHOTREXATE CNS PROPHYLAXIS IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): A MULTICENTRE ANALYSIS OF TOXICITY AND IMPACT ON R-CHOP DELIVERY

EHA Library, Matthew Wilson, 295056

CONDITIONAL RELATIVE SURVIVAL OF ADULT PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA IN THE RITUXIMAB ERA: A NATIONWIDE, POPULATION-BASED STUDY IN THE NETHERLANDS, 2003-2017

EHA Library, Mujde Durmaz, 295057

RE-MIND STUDY: COMPARISON OF TAFASITAMAB + LENALIDOMIDE (L-MIND) VS LENALIDOMIDE MONOTHERAPY (REAL-WORLD DATA) IN TRANSPLANT-INELIGIBLE PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Pier Luigi Zinzani, 295058

CHARACTERISTICS AND OUTCOMES OF HIV-RELATED BURKITT LYMPHOMA (HIV-BL) IN THE POST-RITUXIMAB ERA ACROSS 30 US CANCER CENTERS

EHA Library, Juan Pablo Alderuccio, 295059

PHASE 1 ALEXANDER STUDY OF AUTO3 THE FIRST BICISTRONIC CHIMERIC ANTIGEN RECEPTOR (CAR) TARGETING CD19 AND CD22 WITH PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA

EHA Library, Wendy Osborne, 295060

EFFICACY AND SAFETY OF SEQUENTIAL ADMINISTRATION OF CAR T CELLS TARGETING DIFFERENT B CELL ANTIGEN IN CHILDREN WITH REFRACTORY/RELAPSED BURKITT LYMPHOMA

EHA Library, Ying Liu, 295062

OUTCOME OF HIGH-GRADE LYMPHOMA PATIENTS TREATED WITH CD19 CAR-T – UPDATED REAL-WORLD EXPERIENCE IN THE UK

EHA Library, Andrea Kuhnl, 295063

LISOCABTAGENE MARALEUCEL FOR TREATMENT OF SECOND-LINE TRANSPLANT NONELIGIBLE RELAPSED/REFRACTORY AGGRESSIVE LARGE B-CELL NON-HODGKIN LYMPHOMA: UPDATED RESULTS FROM THE PILOT STUDY

EHA Library, Nilanjan Ghosh, 295064

GENOMIC AND EPIGENOMIC INSIGHTS INTO THE ORIGIN, PATHOGENESIS AND CLINICAL BEHAVIOR OF MANTLE CELL LYMPHOMA SUBTYPES

EHA Library, Silvia Bea, 295065

INTEGRATIVE ANALYSIS OF THE GENOMIC LANDSCAPE OF HODGKIN LYMPHOMA USING LIQUID BIOPSIES

EHA Library, Sven Borchmann, 295066

SHMT2 CONTROLS BURKITT LYMPHOMA CELL SURVIVAL BY MAINTAINING ONCOGENIC TCF3 FUNCTION

EHA Library, Anne Christine Wilke, 295067

BASELINE TP53 MUTATIONS AND MOLECULAR REMISSION ARE BIOMARKERS OF RESPONSE TO TREATMENT WITH IBRUTINIB PLUS NIVOLUMAB IN RELAPSED/REFRACTORY DLBCL

EHA Library, Alessio Bruscaggin, 295068

PREDICTING PEMBROLIZUMAB RESPONSE BY HIGHLY MULTIPLEXED TUMOR IMAGING

EHA Library, Christian Schürch, 295069

CLONAL DYNAMICS AND GENOMIC INTEGRITY OF HEMATOPOIETIC STEM AND PROGENITOR CELLS IN HUMAN ALLOGENEIC TRANSPLANT RECIPIENTS

EHA Library, Mirjam Belderbos, 295070

IMPACT OF CONDITIONING INTENSITY AND GENOMICS ON RELAPSE AFTER ALLOGENEIC TRANSPLANTATION FOR PATIENTS WITH MYELODYSPLASTIC SYNDROME

EHA Library, Christopher Hourigan, 295071

PATIENTS' CYTOTOXICITY AGAINST MSC AS BIOMARKER TO IDENTIFY RESPONDING PATIENTS IN GRAFT-VERSUS-HOST DISEASE

EHA Library, Antonio Galleu, 295072

COMBINED TREATMENT OF CHRONIC GRAFT VERSUS HOST DISEASE USING REGULATORY T CELLS AND RUXOLITINIB

EHA Library, Virginia Escamilla Gómez, 295073

ARSENIC TRIOXIDE ALLEVIATES ACUTE GRAFT-VERSUS-HOST DISEASE BY MODULATING MACROPHAGE POLARIZATION

EHA Library, Xiao Liu, 295074

RUXOLITINIB VERSUS BEST AVAILABLE THERAPY IN PATIENTS WITH STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE: OVERALL RESPONSE RATE BY BASELINE CHARACTERISTICS IN THE RANDOMIZED PHASE 3 REACH2 TRIAL

EHA Library, Robert Zeiser, 295075

GRAVITAS-301: A RANDOMIZED, DOUBLE-BLIND PHASE 3 STUDY OF ITACITINIB OR PLACEBO IN COMBINATION WITH CORTICOSTEROIDS FOR INITIAL TREATMENT OF PATIENTS WITH ACUTE GRAFT-VERSUS-HOST DISEASE

EHA Library, Robert Zeiser, 295076

PROGNOSTIC FACTORS AND LONG-TERM FOLLOW-UP OF BASILIXIMAB FOR STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE: UPDATED EXPERIENCES FROM A LARGE-SCALE STUDY

EHA Library, Si-Ning Liu, 295077

EARLY MEASUREMENT OF ST2 AND REG3 HAS A PREDICTIVE VALUE IN HAPLOIDENTICAL TRANSPLANTATION WITH POST-TRASPLANT CYCLOPHOSPHAMIDE OUTCOME

EHA Library, Marta Fonseca, 295078

DEVELOPMENT AND VALIDATION OF A MACHINE-LEARNING GRADING SYSTEM FOR ACUTE GRAFT-VERSUS-HOST DISEASE

EHA Library, Amin Turki, 295079

LOW-DOSE DECITABINE IMPROVES REFRACTORY PROLONGED ISOLATED THROMBOCYTOPENIA AFTER HEMATOPOIETIC CELL TRANSPLANTATION: A RANDOMIZED MULTICENTER CLINICAL TRIAL

EHA Library, Yue Han, 295080

SINGLE CORD BLOOD TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA PATIENTS AGED 60 YEARS OR OLDER: A RETROSPECTIVE STUDY OF THE JAPAN SOCIETY FOR HEMATOPOIETIC CELL TRANSPLANTATION (JSHCT)

EHA Library, Masamichi Isobe, 295081

NARSOPLIMAB (OMS721) FOR THE TREATMENT OF ADULT HEMATOPOIETIC STEM CELL TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY

EHA Library, Alessandro Rambaldi, 295082

COMPARISON OF RISK FACTORS AND MORTALITY OF DIFFERENT CYTOMEGALOVIRUS END-ORGAN DISEASES FOLLOWING HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, xing-ye meng, 295083

ADOPTIVE IMMUNOTHERAPY WITH REGULATORY AND CONVENTIONAL T CELLS AFFORDS HIGH RATE OF CHRONIC GVHD/RELAPSE-FREE SURVIVAL IN ACUTE MYELOID LEUKEMIA AFTER MYELOABLATIVE HAPLOIDENTICAL TRANSPLANTATION

EHA Library, Antonio Pierini, 295084

OUTCOME OF HAEMATOPOIETIC CELL TRANSPLANTATION IN CHILDREN WITH FANCONI ANAEMIA: A STUDY ON BEHALF OF THE EBMT SAAWP AND PDWP

EHA Library, Su Han Lum, 295085

A DOUBLE-INSURANCE DUAL HSCT IN PATIENT WITH THALASSEMIA MAJOR: POST-TRANSPLANT CYCLOPHOSPHAMIDE HAPLO-HSCT FOLLOWED BY UNRELATED CORD BLOOD TRANSPLANTATION

EHA Library, Chunfu Li, 295086

OUTCOME OF T-CELL-REPLETE HAPLOIDENTICAL STEM CELL TRANSPLANTATION IMPROVE WITH TIME IN ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA: A STUDY FROM THE ACUTE LEUKEMIA WORKING PARTY OF THE EBMT

EHA Library, Arnon Nagler, 295087

POST-TRANSPLANT CYCLOPHOSPHAMIDE PROVIDES SIMILAR OUTCOMES TO ANTITHYMOCYTE GLOBULIN IN HLA-MATCHED UNRELATED DONOR TRANSPLANTATION

EHA Library, Eolia Brissot, 295088

IMPACT OF DIFFERENT EX VIVO T-CELL DEPLETION STRATEGIES ON OUTCOMES FOLLOWING HEMATOPOIETIC CELL TRANSPLANTATION FOR CHILDREN WITH PRIMARY IMMUNODEFICIENCY

EHA Library, Su Han Lum, 295089

EPIGENETIC BLUEPRINT OF HUMAN THYMOPOIESIS REVEALS MOLECULAR MECHANISMS OF STAGE-SPECIFIC TCR ENHANCER ACTIVATION

EHA Library, Agata Cieslak, 295090

THE GERMLINE GATA2 R396Q MISSENSE MUTATION FUNCTIONALLY AND QUALITATIVELY ALTERS HEMATOPOIETIC STEM CELL COMPARTMENT IN MICE.

EHA Library, Laetitia Largeaud, 295091

UROLITHIN-A INDUCED METABOLIC REPROGRAMMING OF HEMATOPOIETIC STEM CELL FUNCTION

EHA Library, Mukul Girotra, 295092

THE MESENCHYMAL STEM CELL NICHE REGULATES THE REDOX BALANCE IN ACUTE MYELOID LEUKEMIA INITIATING CELLS.

EHA Library, Borja Saez, 295093

COMBINED SINGLE-CELL DNA METHYLOME AND TRANSCRIPTOME ANALYSIS FACILITATES DECONVOLUTION OF HEMATOPOIETIC COMMITMENT DECISIONS

EHA Library, Sina Stäble, 295094

MULTIVARIATE SUPERVISED LEARNING OF LISOCABTAGENE MARALEUCEL (LISO-CEL) CAR T CELL PRODUCT AND PATIENT CHARACTERISTICS IDENTIFIES ATTRIBUTES ASSOCIATED WITH CLINICAL ENDPOINTS IN LARGE B-CELL LYMPHOMA

EHA Library, Yue Jiang, 295095

MICRORNA-146A REGULATES IMMUNOTHERAPY INDUCED IMMUNE-RELATED ADVERSE EVENTS IN MICE AND HUMANS

EHA Library, Natalie Köhler, 295096

EX-VIVO HEMATOPOIETIC STEM CELL EXPANSION SYSTEM AS A PLATFORM FOR GENE EDITING

EHA Library, Hans Jiro Becker, 295097

'CERBERUS' T CELLS: A SINGLE GLUCOCORTICOID-RESISTANT T CELL PRODUCT TO SIMULTANEOUSLY TARGET MULTIPLE PATHOGENS IN IMMUNOCOMPROMISED PATIENTS

EHA Library, Anastasia Papadopoulou, 295098

CD7 NANOBODY-DERIVED ANTI-CD7 CHIMERIC ANTIGEN RECEPTOR T-CELLS EXHIBITED POTENT ANTI-TUMOR ACTIVITIES TO CD7 POSITIVE MALIGNANCIES

EHA Library, Dan Chen, 295099

INITIAL SAFETY AND EFFICACY RESULTS WITH A SINGLE DOSE OF AUTOLOGOUS CRISPR-CAS9 MODIFIED CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS IN TRANSFUSION-DEPENDENT Β-THALASSEMIA AND SICKLE CELL DISEASE

EHA Library, Selim Corbacioglu, 295100

FIRST-IN-HUMAN PHASE I/II CLINICAL TRIAL OF HEMATOPOIETIC STEM CELL-GENE THERAPY FOR MUCOPOLYSACCHARIDOSIS TYPE I, HURLER (MPS-IH): PRELIMINARY EVIDENCE OF EXTENSIVE METABOLIC CORRECTION

EHA Library, Maria Ester Bernardo, 295101

OUTCOMES IN PATIENTS TREATED WITH LENTIGLOBIN FOR SICKLE CELL DISEASE (SCD) GENE THERAPY: UPDATED RESULTS FROM THE PHASE 1/2 HGB-206 GROUP C STUDY

EHA Library, Julie Kanter, 295102

AUTOLOGOUS CD34+ ENRICHED HEMATOPOIETIC PROGENITOR CELLS GENETICALLY MODIFIED FOR HUMAN INTERFERON-ALPHA2, RAPIDLY ENGRAFT AND MATURE IN PATIENTS WITH GLIOBLASTOMA MULTIFORME (TEM-GBM_001 STUDY)

EHA Library, Fabio Ciceri, 295103

EARLY-PHASE CLINICAL TRIALS OF ADOPTIVE TRANSFER OF HYPERFUNCTIONAL NK CELLS EXPANDED EX VIVO WITH IL-21 DEMONSTRATE FUNCTIONAL, PHENOTYPIC, AND HAPLOTYPE-SPECIFIC EVIDENCE OF IN VIVO PERSISTENCE

EHA Library, Dean A Lee, 295104

DONOR-DERIVED SLEEPING BEAUTY CD19 CAR CYTOKINE INDUCED KILLER (CIK) CELLS EXPAND AND PERSIST IN CHILDREN AND ADULTS WITH B-ALL RELAPSED POST HSCT

EHA Library, Chiara F Magnani, 295105

INTERIM ANALYSIS OF ZUMA-5: A PHASE 2 STUDY OF AXICABTAGENE CILOLEUCEL (AXI-CEL) IN PATIENTS WITH RELAPSED/REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA

EHA Library, Caron A. Jacobson, 295106

CART19-BE-01: A EUROPEAN ACADEMIC TRIAL ON THE ADMINISTRATION OF ARI-0001 CELLS IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AND OTHER CD19+ LYMPHOPROLIFERATIVE DISORDERS

EHA Library, Valentín Ortiz-Maldonado, 295107

FIRST-IN-HUMAN CLINICAL TRIAL OF THE AUTOLOGOUS CD7-CART CELLS FOR PATIENTS WITH RELAPSED AND REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA

EHA Library, Mingzhi Zhang, 295108

IMR-687, A HIGHLY SELECTIVE PHOSPHODIESTERASE 9 INHIBITOR (PDE9I), INCREASES F-CELLS AND FETAL HEMOGLOBIN IN A PH-2A INTERIM ANALYSIS

EHA Library, Biree Andemariam, 295109

CAL-H, A NOVEL SELF-INACTIVATING LENTIVIRAL VECTOR ENCODING HUMAN Y-GLOBIN(G16D) AND SHRNA734 INHIBITS SICKLING IN RBC DERIVED FROM CD34+ STEM/PROGENITOR CELLS OF SICKLE CELL DISEASE PATIENTS

EHA Library, Waleed Ghanima, 295110

EDIT-301: AN AUTOLOGOUS CELL THERAPY TO PROMOTE FETAL HEMOGLOBIN EXPRESSION FOR THE POTENTIAL TREATMENT OF SICKLE CELL DISEASE

EHA Library, Jack Heath, 295111

THE ORAL FERROPORTIN INHIBITOR VIT-2763 IMPROVES ERYTHROPOIESIS WITHOUT INTERFERING WITH IRON CHELATION THERAPY IN A MODEL OF BETA-THALASSEMIA

EHA Library, Naja Nyffenegger, 295112

THE ORAL FERROPORTIN INHIBITOR VIT-2763 PREVENTS HEMOLYSIS AND VASO-OCCLUSION IN A SICKLE CELL DISEASE MODEL

EHA Library, Vania Manolova, 295113

ASSESSMENT OF RESPONSE TO LUSPATERCEPT BY Β-GLOBIN GENOTYPE IN ADULT PATIENTS WITH Β-THALASSEMIA IN THE BELIEVE TRIAL

EHA Library, Maria Domenica Cappellini, 295114

IMPROVEMENT IN ERYTHROPOIESIS IN PATIENTS WITH TRANSFUSION-DEPENDENT B-THALASSEMIA FOLLOWING TREATMENT WITH BETIBEGLOGENE AUTOTEMCEL (LENTIGLOBIN FOR B-THALASSEMIA) IN THE PHASE 3 HGB-207 STUDY

EHA Library, John B. Porter, 295115

PROOF OF CONCEPT FOR THE ORAL PYRUVATE KINASE ACTIVATOR MITAPIVAT IN ADULTS WITH NON–TRANSFUSION-DEPENDENT THALASSEMIA: INTERIM RESULTS FROM AN ONGOING, PHASE 2, OPEN-LABEL, MULTICENTER STUDY

EHA Library, Kevin HM Kuo, 295116

A HEPCIDIN MIMETIC, PTG-300, DEMONSTRATES PHARMACODYNAMIC EFFECTS INDICATING REDUCED IRON AVAILABILITY IN TRANSFUSION-DEPENDENT BETA-THALASSEMIA SUBJECTS

EHA Library, Ashutosh Lal, 295117

HEMATOPOIETIC STEM CELLS WITH ERYTHROID SIGNATURE IN BETA-THALASSEMIA

EHA Library, Maria Rosa Lidonnici, 295118

WHOLE EXOME SEQUENCING OF A PATIENT WITH ATYPICAL CONGENITAL PURE RED CELL APLASIA HAS ENABLED THE IDENTIFICATION OF A NOVEL KEY ACTOR OF ERYTHROPOIESIS

EHA Library, Elia Colin, 295119

UNEXPLAINED SPLENOMEGALIES: INTERIM DATA OF THE FRENCH PROSPECTIVE MULTI-CENTER SPLENOMEGALY STUDY (SMS)

EHA Library, Guillaume Denis, 295120

METABOLIC PHENOTYPING FOR RARE HEREDITARY ANEMIA - APPLICATION FOR PYRUVATE KINASE DEFICIENCY

EHA Library, Birgit van Dooijeweert, 295121

CHARACTERIZATION OF THE ROLE OF C15ORF41 IN THE PHYSIOLOGICAL AND PATHOLOGICAL ERYTHROPOIESIS

EHA Library, Roberta Marra, 295122

ROLE OF FERROPTOSIS IN X-LINKED SIDEROBLASTIC ANEMIA

EHA Library, Koya Ono, 295123

HYPOFERREMIA CAUSED BY TLR2-CONTROLLED FERROPORTIN DOWNREGULATION IS MEDIATED BY NFKB THROUGH HDAC-DEPENDENT AND -INDEPENDENT MECHANISMS

EHA Library, Oriana Marques, 295124

TRANSFERRIN RECEPTOR 2 TARGETING AMELIORATES ANEMIA OF CHRONIC KIDNEY DISEASE

EHA Library, Violante Olivari, 295125

COMBINATORIAL TARGETING OF THE TWO HEPCIDIN INHIBITORS FKBP12 AND TMPRSS6 TO UPREGULATE HEPCIDIN IN MICE.

EHA Library, Mariateresa Pettinato, 295126

SELECTIVE INHIBITION OF ALK2 SIGNALING AMELIORATES DISEASE IN A NOVEL MODEL OF IRON REFRACTORY IRON DEFICIENCY ANEMIA (IRIDA).

EHA Library, Thomas Backus, 295127

ELEVATED LIVER IRON INCREASES GLUCONEOGENESIS IN BETA-THALASSEMIA MICE

EHA Library, Heinrich Lob, 295128

SHORT VERSUS EXTENDED ANTIBIOTIC TREATMENT WITH A CARBAPENEM FOR HIGH-RISK FEBRILE NEUTROPENIA IN HEMATOLOGY PATIENTS WITH FEVER OF UNKNOWN ORIGIN: A RANDOMIZED MULTICENTER NON-INFERIORITY TRIAL.

EHA Library, Nick De Jonge, 295129

STOPPING ANTIBIOTIC THERAPY AFTER 72 HOURS IN PATIENTS WITH FEBRILE NEUTROPENIA UNDERGOING INTENSIVE CHEMOTHERAPY FOR AML/MDS (SAFE STUDY): A RETROSPECTIVE COMPARATIVE COHORT STUDY

EHA Library, Alexander Schauwvlieghe, 295130

A RANDOMISED TRIAL OF TWO 2-DOSE INFLUENZA VACCINATION STRATEGIES FOR PATIENTS FOLLOWING AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Ben Teh, 295131

DIAGNOSTIC YIELD OF BRONCHOALVEOLAR LAVAGE (BAL) IN HAEMATOLOGICAL PATIENTS - SINGLE CENTRE 14 YEARS EXPERIENCE

EHA Library, Martina Palackova, 295132

ANTI-CD 19 CHIMERIC ANTIGEN RECEPTORS T-CELLS (CAR T) FOR AGGRESSIVE NON HODGKIN LYMPHOMA (NHL) AND INFECTIOUS COMPLICATIONS. A MONOCENTRIC EXPERIENCE.

EHA Library, Roberta Di Blasi, 295133

ANKRD26: A NEW REGULATOR OF CYTOKINE-MEDIATED SIGNALING

EHA Library, Francesca Basso-Valentina, 295134

SAFETY AND EFFICACY OF RILZABRUTINIB (PRN1008), AN ORAL BRUTON TYROSINE KINASE INHIBITOR, IN RELAPSED/REFRACTORY PATIENTS WITH PRIMARY OR SECONDARY IMMUNE THROMBOCYTOPENIA: PHASE I/II ADAPTIVE STUDY

EHA Library, David Kuter, 295135

GLUCOCORTICOID RECEPTOR MODULATES MYELOID-DERIVED SUPPRESSOR CELLS FUNCTION VIA MITOCHONDRIAL METOBOLISM IN IMMUNE THROMBOCYTOPENIA

EHA Library, Shaoqiu Leng, 295136

SELECTIVE IMMUNOPROTEASOME INHIBITOR, KZR-616, A NOVEL THERAPY FOR AUTOIMMUNE HEMOLYTIC ANEMIA AND IMMUNE THROMBOCYTOPENIA: BIOMARKER ACTIVITY AND PHASE II CLINICAL TRIAL IN PROGRESS (MARINA)

EHA Library, Julia Lawrence, 295137

CLINICAL SPECTRUM, OUTCOME AND MANAGEMENT OF IMMUNE THROMBOCYTOPENIA ASSOCIATED WITH MYELODYSPLASTIC SYNDROME AND CHRONIC MYELOMONOCYTIC LEUKEMIA

EHA Library, Vincent Jachiet, 295138

AN INTERNATIONAL MULTICENTER STUDY OF SYSTEMIC BEVACIZUMAB FOR BLEEDING IN HEREDITARY HEMORRHAGIC TELANGIECTASIA: THE INHIBIT-BLEED STUDY

EHA Library, Hanny Al-Samkari, 295139

NOVEL MANIFESTATIONS OF IMMUNE DYSREGULATION AND GRANULE DEFECTS IN GRAY PLATELET SYNDROME

EHA Library, Janine Collins, 295140

NEW INSIGHTS INTO HEMOPHILIA B LEYDEN

EHA Library, Saad Ahmed, 295141

CHARACTERIZATION OF THE PLATELET DISORDER CAUSED BY RUNX1 GERMLINE MUTATION IN A CRISPR/CAS9-GENERATED MURINE MODEL

EHA Library, Ana Marin Quilez, 295142

VTE-BLEED SCORE TO PREDICT BLEEDING COMPLICACTIONS IN PATIENS WITH VENOUS THROMBOEMBOLISM: FROM THE RIETE REGISTRY

EHA Library, Marta Hidalgo, 295143

UNDERLYING CANCER IN PATIENTS WITH ARTERIAL THROMBOEMBOLISM

EHA Library, Avi Leader, 295144

WHOLE EXOME ANALYSIS IDENTIFIED TWO NEW GENETIC VARIANTS CAUSING ANTITHROMBIN DEFICIENCY BY A SPECIFIC INEFFICIENT N-GLYCOSYLATION: IDENTIFICATION OF A NON-CANONICAL RESIDUE (LYS) AFFECTING N-SEQUONS.

EHA Library, Maria Eugenia de la Morena-Barrio, 295145

INCREASED RISK OF VENOUS AND ARTERIAL THROMBOSIS IN ALK-REARRANGED LUNG CANCER

EHA Library, Hanny Al-Samkari, 295146

A THROMBIN GENERATION-BASED RISK SCORE PREDICTS FOR EARLY DISEASE RECURRENCE IN HIGH-RISK BREAST CANCER PATIENTS: VALIDATION BY TWO DIFFERENT THROMBIN GENERATION ASSAYS

EHA Library, Patricia Gomez Rosas, 295147

IMPACT OF COLD AGGLUTININ DISEASE REAL-WORLD TREATMENTS ON THROMBOSIS AND MORTALITY—A UNITED STATES ELECTRONIC HEATH RECORD DATABASE ANALYSIS

EHA Library, Jun Su, 295148

IMPLEMENTATION OF THE HM-PRO IN CLINICAL PRACTICE: HAEMATOLOGISTS' EXPERIENCE

EHA Library, Tatyana Ionova, 295149